Client experiences a significant loss in revenue after a PBM and its health plan and employer clients exclude one of its brands from its national preferred drug list
The Solution
Organize in-depth virtual meetings between national and regional account directors
Use insights to form a cohesive account strategy and increase rebate amount
Refresh messaging to include stronger clinical and financial evidence
The Results
A reversal of the initial exclusion
Prevention of removal from other PBM’s preferred list
A reversal of the initial exclusion Prevention of removal from other PBM’s preferred list
Contact Us
Results Matter.
Ask us how we can help you utilize clinical and financial evidence.